Involvement of CD73, equilibrative nucleoside transporters and inosine in rhythm and conduction disturbances mediated by adenosine A1 and A2A receptors in the developing heart

Journal of Molecular and Cellular Cardiology

Volumn 63, Issue , 2013, Pages 14-25

  Robin, Elodie ^a   Sabourin, Jessica ^a   Marcillac, Fabrice ^a   Raddatz, Eric ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Adenosine; Arrhythmias; Autocrine paracrine; Embryo; Inosine; Nucleoside transporters

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5' NUCLEOTIDASE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; CD39 ANTIGEN; CONCENTRATIVE NUCLEOSIDE TRANSPORTER; DIPYRIDAMOLE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 3; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 4; INOSINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NUCLEOSIDE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; HEART ATRIUM; HEART ATRIUM ARRHYTHMIA; HEART BEAT; HEART DEVELOPMENT; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE VARIABILITY; HEART VENTRICLE; NONHUMAN; P WAVE; PHOSPHOHYDROLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN METABOLISM; PROTEIN TRANSPORT; QT INTERVAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADENOSINE; ADENOSINE RECEPTOR; ADO; AR; ARRHYTHMIAS; ATRIO-VENTRICULAR BLOCK; AUTOCRINE/PARACRINE; AVB; EADA; ECTO ADENOSINE DEAMINASE; EMBRYO; INO; INOSINE; NUCLEOSIDE TRANSPORTERS;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; ARRHYTHMIAS, CARDIAC; CHICK EMBRYO; ENZYME ACTIVATION; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; HEART; HEART ATRIA; HEART CONDUCTION SYSTEM; HEART VENTRICLES; INOSINE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MYOCARDIUM; PHOSPHORYLATION; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; SIGNAL TRANSDUCTION;

EID: 84881500297     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.06.008     Document Type: Article

References (89)

1. Rivkees S.A., Wendler C.C. Regulation of cardiovascular development by adenosine and adenosine-mediated embryo protection. Arterioscler Thromb Vasc Biol 2012, 32:851-855.
2. Porter G.A., Rivkees S.A. Ontogeny of humoral heart rate regulation in the embryonic mouse. Am J Physiol Regul Integr Comp Physiol 2001, 281:401-407.
3. Hofman P.L., Hiatt K., Yoder M.C., Rivkees S.A. A1 adenosine receptors potently regulate heart rate in mammalian embryos. Am J Physiol 1997, 273:1374-1380.
4. Burnstock G., Ulrich H. Purinergic signaling in embryonic and stem cell development. Cell Mol Life Sci 2011, 68:1369-1394.
5. Ghatpande S.K., Billington C.J., Rivkees S.A., Wendler C.C. Hypoxia induces cardiac malformations via A1 adenosine receptor activation in chicken embryos. Birth Defects Res A Clin Mol Teratol 2008, 82:121-130.
6. Romano R., Rochat A.C., Kucera P., De Ribaupierre Y., Raddatz E. Oxidative and glycogenolytic capacities within the developing chick heart. Pediatr Res 2001, 49:363-372.
7. Raddatz E., Servin M., Kucera P. Oxygen uptake during early cardiogenesis of the chick. Am J Physiol 1992, 262:1224-1230.
8. Headrick J.P., Peart J.N., Reichelt M.E., Haseler L.J. Adenosine and its receptors in the heart: regulation, retaliation and adaptation. Biochim Biophys Acta 1808, 2011:1413-1428.
9. Wendler C.C., Amatya S., McClaskey C., Ghatpande S., Fredholm B.B., Rivkees S.A. A1 adenosine receptors play an essential role in protecting the embryo against hypoxia. Proc Natl Acad Sci U S A 2007, 104:9697-9702.
10. Wendler C.C., Poulsen R.R., Ghatpande S., Greene R.W., Rivkees S.A. Identification of the heart as the critical site of adenosine mediated embryo protection. BMC Dev Biol 2010, 10:57.
11. Robin E., Sabourin J., Benoit R., Pedretti S., Raddatz E. Adenosine A1 receptor activation is arrhythmogenic in the developing heart through NADPH oxidase/ERK- and PLC/PKC-dependent mechanisms. J Mol Cell Cardiol 2011, 51:945-954.
12. Sabourin J., Antigny F., Robin E., Frieden M., Raddatz E. Activation of transient receptor potential canonical 3 (TRPC3)-mediated Ca2+ entry by A1 adenosine receptor in cardiomyocytes disturbs atrioventricular conduction. J Biol Chem 2012, 287:26688-26701.
13. Sabourin J., Robin E., Raddatz E. A key role of TRPC channels in the regulation of electromechanical activity of the developing heart. Cardiovasc Res 2011, 92:226-236.
14. Fredholm B.B. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 2007, 14:1315-1323.
15. Rose J.B., Naydenova Z., Bang A., Ramadan A., Klawitter J., Schram K., et al. Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge. Life Sci 2011, 89:621-630.
16. Shryock J.C., Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 1997, 79:2-10.
17. Takahashi T., Otsuguro K., Ohta T., Ito S. Adenosine and inosine release during hypoxia in the isolated spinal cord of neonatal rats. Br J Pharmacol 2010, 161:1806-1816.
18. Mallet M.L. Proarrhythmic effects of adenosine: a review of the literature. Emerg Med J 2004, 21:408-410.
19. Szentmiklosi A.J., Cseppento A., Harmati G., Nanasi P.P. Novel trends in the treatment of cardiovascular disorders: site- and event-selective adenosinergic drugs. Curr Med Chem 2011, 18:1164-1187.
20. Viskin S., Rosso R., Rogowski O., Belhassen B., Levitas A., Wagshal A., et al. Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. Eur Heart J 2006, 27:469-475.
21. Deussen A., Stappert M., Schafer S., Kelm M. Quantification of extracellular and intracellular adenosine production: understanding the transmembranous concentration gradient. Circulation 1999, 99:2041-2047.
22. Cunha R.A., Vizi E.S., Ribeiro J.A., Sebastiao A.M. Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem 1996, 67:2180-2187.
23. Deussen A. Metabolic flux rates of adenosine in the heart. Naunyn Schmiedebergs Arch Pharmacol 2000, 362:351-363.
24. Willems L., Reichelt M.E., Molina J.G., Sun C.X., Chunn J.L., Ashton K.J., et al. Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts. Cardiovasc Res 2006, 71:79-87.
25. Saura C.A., Mallol J., Canela E.I., Lluis C., Franco R. Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem 1998, 273:17610-17617.
26. Molina-Arcas M., Casado F.J., Pastor-Anglada M. Nucleoside transporter proteins. Curr Vasc Pharmacol 2009, 7:426-434.
27. Rose J.B., Coe I.R. Physiology of nucleoside transporters: back to the future. Physiology (Bethesda) 2008, 23:41-48.
28. Podgorska M., Kocbuch K., Pawelczyk T. Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transporters. Acta Biochim Pol 2005, 52:749-758.
29. dos Santos-Rodrigues A., Ferreira J.M., Paes-de-Carvalho R. Differential adenosine uptake in mixed neuronal/glial or purified glial cultures of avian retinal cells: modulation by adenosine metabolism and the ERK cascade. Biochem Biophys Res Commun 2011, 414:175-180.
30. de Carvalho R.P., Braas K.M., Adler R., Snyder S.H. Developmental regulation of adenosine A1 receptors, uptake sites and endogenous adenosine in the chick retina. Brain Res Dev Brain Res 1992, 70:87-95.
31. Modis K., Gero D., Nagy N., Szoleczky P., Toth Z.D., Szabo C. Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis. Br J Pharmacol 2009, 158:1565-1578.
32. Naydenova Z., Rose J.B., Coe I.R. Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line. Am J Physiol Heart Circ Physiol 2008, 294:2687-2692.
33. Farthing D., Xi L., Gehr L., Sica D., Larus T., Karnes H.T. High-performance liquid chromatography (HPLC) determination of inosine, a potential biomarker for initial cardiac ischaemia, using isolated mouse hearts. Biomarkers 2006, 11:449-459.
34. Fredholm B.B., Irenius E., Kull B., Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 2001, 61:443-448.
35. Tilley S.L., Wagoner V.A., Salvatore C.A., Jacobson M.A., Koller B.H. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest 2000, 105:361-367.
36. Askalan R., Richardson P.J. Role of histidine residues in the adenosine A2a receptor ligand binding site. J Neurochem 1994, 63:1477-1484.
37. Gomez G., Sitkovsky M.V. Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 2003, 102:4472-4478.
38. Assaife-Lopes N., Wengert M., de Sa Pinheiro A.A., Leao-Ferreira L.R., Caruso-Neves C. Inhibition of renal Na+-ATPase activity by inosine is mediated by A1 receptor-induced inhibition of the cAMP signaling pathway. Arch Biochem Biophys 2009, 489:76-81.
39. Jin X., Shepherd R.K., Duling B.R., Linden J. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 1997, 100:2849-2857.
40. da Rocha Lapa F., da Silva M.D., de Almeida Cabrini D., Santos A.R. Anti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A2 receptors. Purinergic Signal 2012, 8:693-704.
41. da Rocha Lapa F., de Oliveira A.P., Accetturi B.G., de Oliveira Martins I., Domingos H.V., de Almeida Cabrini D., et al. Anti-inflammatory effects of inosine in allergic lung inflammation in mice: evidence for the participation of adenosine A(2A) and A (3) receptors. Purinergic Signal 2013, (in press).
42. Nascimento F.P., Figueredo S.M., Marcon R., Martins D.F., Macedo S.J., Lima D.A., et al. Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways. J Pharmacol Exp Ther 2010, 334:590-598.
43. Hasko G., Sitkovsky M.V., Szabo C. Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 2004, 25:152-157.
44. Liaudet L., Mabley J.G., Soriano F.G., Pacher P., Marton A., Hasko G., et al. Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Care Med 2001, 164:1213-1220.
45. Guinzberg R., Cortes D., Diaz-Cruz A., Riveros-Rosas H., Villalobos-Molina R., Pina E. Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors. Am J Physiol Endocrinol Metab 2006, 290:940-951.
46. Shen H., Chen G.J., Harvey B.K., Bickford P.C., Wang Y. Inosine reduces ischemic brain injury in rats. Stroke 2005, 36:654-659.
47. Gardier S., Pedretti S., Sarre A., Raddatz E. Transient anoxia and oxyradicals induce a region-specific activation of MAPKs in the embryonic heart. Mol Cell Biochem 2010, 340:239-247.
48. Hamburger V., Hamilton H.L. A series of normal stages in the development of the chick embryo. J Morphol 1951, 88:49.
49. Sarre A., Maury P., Kucera P., Kappenberger L., Raddatz E. Arrhythmogenesis in the developing heart during anoxia-reoxygenation and hypothermia-rewarming: an in vitro model. J Cardiovasc Electrophysiol 2006, 17:1350-1359.
50. Conde S.V., Monteiro E.C. Hypoxia induces adenosine release from the rat carotid body. J Neurochem 2004, 89:1148-1156.
51. Hedeker D., Gibbons R. Longitudinal Data Analysis 2006, 148-151. Wiley.
52. Skrondal A., Rabe-Hesketh S. Multilevel logistic regression for polytomous data and rankings. Psychometrika 2003, 68:267-287.
53. Ciruela F., Saura C., Canela E.I., Mallol J., Lluis C., Franco R. Ligand-induced phosphorylation, clustering, and desensitization of A1 adenosine receptors. Mol Pharmacol 1997, 52:788-797.
54. Franco R., Casado V., Ciruela F., Saura C., Mallol J., Canela E.I., et al. Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol 1997, 52:283-294.
55. Herrera C., Casado V., Ciruela F., Schofield P., Mallol J., Lluis C., et al. Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol Pharmacol 2001, 59:127-134.
56. Sun W.C., Cao Y., Jin L., Wang L.Z., Meng F., Zhu X.Z. Modulating effect of adenosine deaminase on function of adenosine A1 receptors. Acta Pharmacol Sin 2005, 26:160-165.
57. Saura C., Ciruela F., Casado V., Canela E.I., Mallol J., Lluis C., et al. Adenosine deaminase interacts with A1 adenosine receptors in pig brain cortical membranes. J Neurochem 1996, 66:1675-1682.
58. Gracia E., Perez-Capote K., Moreno E., Barkesova J., Mallol J., Lluis C., et al. A2A adenosine receptor ligand binding and signalling is allosterically modulated by adenosine deaminase. Biochem J 2011, 435:701-709.
59. Manthei S.A., Reiling C.M., Van Wylen D.G. Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition. Cardiovasc Res 1998, 37:171-178.
60. Sandhu G.S., Burrier A.C., Janero D.R. Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart. Am J Physiol 1993, 265:1249-1256.
61. Silva P.H., Dillon D., Van Wylen D.G. Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Cardiovasc Res 1995, 29:616-623.
62. Chaudary N., Shuralyova I., Liron T., Sweeney G., Coe I.R. Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes. Biochem Cell Biol 2002, 80:655-665.
63. Chaudary N., Naydenova Z., Shuralyova I., Coe I.R. The adenosine transporter, mENT1, is a target for adenosine receptor signaling and protein kinase Cepsilon in hypoxic and pharmacological preconditioning in the mouse cardiomyocyte cell line, HL-1. J Pharmacol Exp Ther 2004, 310:1190-1198.
64. Chaudary N., Naydenova Z., Shuralyova I., Coe I.R. Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1. Cardiovasc Res 2004, 61:780-788.
65. Young J.D., Yao S.Y., Sun L., Cass C.E., Baldwin S.A. Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica 2008, 38:995-1021.
66. Eltzschig H.K., Abdulla P., Hoffman E., Hamilton K.E., Daniels D., Schonfeld C., et al. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 2005, 202:1493-1505.
67. Moser G.H., Schrader J., Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol 1989, 256:799-806.
68. Barankiewicz J., Cohen A. Purine nucleotide metabolism in resident and activated rat macrophages in vitro. Eur J Immunol 1985, 15:627-631.
69. Abd-Elfattah A.S., Aly H., Hanan S., Wechsler A.S. Myocardial protection in beating heart cardiac surgery: I: pre- or postconditioning with inhibition of es-ENT1 nucleoside transporter and adenosine deaminase attenuates post-MI reperfusion-mediated ventricular fibrillation and regional contractile dysfunction. J Thorac Cardiovasc Surg 2012, 144:250-255.
70. Ramakers B.P., Riksen N.P., Stal T.H., Heemskerk S., van den Broek P., Peters W.H., et al. Dipyridamole augments the antiinflammatory response during human endotoxemia. Crit Care 2011, 15:289.
71. Wang T., Mentzer R.M., Van Wylen D.G. Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase. Am J Physiol 1992, 263:552-558.
72. de Micheli A., Pastelin G., Chavez Dominguez R., Iturralde Torres P., Medrano G.A. Antiarrhythmic and arrhythmogenic action of inosine in experimental ventricular tachyarrhythmias. Arch Cardiol Mex 2009, 79:175-181.
73. Saboury A.A., Divsalar A., Jafari G.A., Moosavi-Movahedi A.A., Housaindokht M.R., Hakimelahi G.H. A product inhibition study on adenosine deaminase by spectroscopy and calorimetry. J Biochem Mol Biol 2002, 35:302-305.
74. Strasburger J.F., Wakai R.T. Fetal cardiac arrhythmia detection and in utero therapy. Nat Rev Cardiol 2010, 7:277-290.
75. Gray J.H., Owen R.P., Giacomini K.M. The concentrative nucleoside transporter family, SLC28. Pflugers Arch 2004, 447:728-734.
76. Reppel M., Sasse P., Malan D., Nguemo F., Reuter H., Bloch W., et al. Functional expression of the Na+/Ca2+ exchanger in the embryonic mouse heart. J Mol Cell Cardiol 2007, 42:121-132.
77. Tenthorey D., de Ribaupierre Y., Kucera P., Raddatz E. Effects of verapamil and ryanodine on activity of the embryonic chick heart during anoxia and reoxygenation. J Cardiovasc Pharmacol 1998, 31:195-202.
78. Prajapat L., Ariyarajah V., Spodick D.H. Induction of atrial depolarization abnormality during dipyridamole stress imaging: a cautionary note. Cardiology 2008, 110:35-38.
79. Pennell D.J., Ell P.J. Atrial fibrillation after intravenous dipyridamole for thallium imaging. Eur J Nucl Med 1992, 19:1064-1065.
80. Frossard M., Weiss K., Gossinger H., Zeiner A., Leitha T. Asystole during dipyridamole infusion in patients without coronary artery disease or beta-blocker therapy. Clin Nucl Med 1997, 22:97-100.
81. Bielen M., Karsera D., Melon P., Kulbertus H. Severe bradyarrhythmia during myocardial perfusion scintigraphy with injection of dipyridamole (Persantine). Rev Med Liege 1999, 54:105-108.
82. Eckle T., Hughes K., Ehrentraut H., Brodsky K.S., Rosenberger P., Choi D.S., et al. Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury. FASEB J 2013, (in press).
83. Grenz A., Bauerle J.D., Dalton J.H., Ridyard D., Badulak A., Tak E., et al. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 2012, 122:693-710.
84. Weinberg J.M., Venkatachalam M.A. Preserving postischemic reperfusion in the kidney: a role for extracellular adenosine. J Clin Invest 2012, 122:493-496.
85. Santos-Silva A.J., Cairrao E., Morgado M., Alvarez E., Verde I. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries. Eur J Pharmacol 2008, 582:102-109.
86. Harker L.A., Kadatz R.A. Mechanism of action of dipyridamole. Thromb Res Suppl 1983, 4:39-46.
87. Dogne J.M., de Leval X., Benoit P., Delarge J., Masereel B., David J.L. Recent advances in antiplatelet agents. Curr Med Chem 2002, 9:577-589.
88. Mustafa S.J., Morrison R.R., Teng B., Pelleg A. Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol 2009, 161-188.
89. Pelleg A., Hurt C., Miyagawa A., Michelson E.L., Dreifus L.S. Differential sensitivity of cardiac pacemakers to exogenous adenosine in vivo. Am J Physiol 1990, 258:1815-1822.